NASDAQ:HEPA - Nasdaq - US4268973025 - Common Stock
TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 25.36M | 45.26M | 43.62M | 30.40M | 20.15M | |||
Research and Development | 17.88M | 35.64M | 33.27M | 20.40M | 12.00M | |||
Selling, General, and Administrative Expenses | 7.48M | 9.62M | 10.35M | 10.01M | 8.15M | |||
Operating Income | -25.36M | -45.26M | -43.62M | -30.40M | -20.15M | |||
Interest Income/Expense | -431.79K | -9.47K | -10.00K | -2.32M | -180.00K | |||
Other Income/Expense | 2.90M | -877.65K | 410.00K | N/A | N/A | |||
Non Recurring Items | N/A | -3.19M | -1.87M | N/A | N/A | |||
Income Before Taxes | -26.08M | -49.34M | -45.08M | -32.72M | -20.32M | |||
Income Tax | N/A | -409.02K | -2.88M | 0.00 | 30.00K | |||
Net Income | -22.70M | -48.93M | -45.34M | -32.72M | -20.36M | |||
EBITDA | N/A | -45.19M | -43.54M | -30.31M | -20.12M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -4.47 | -12.32 | -11.90 | -9.31 | -42.41 | |||
Non GAAP EPS | N/A | -12.32 | -11.80 | N/A | -2.53 | |||
Statistics |
All data in USD